Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is an experimental small molecule belonging to the class of organic compounds known as phenylpiperazines. It features a pyrrolopyrimidine core substituted with a cyclohexyl group and a benzene ring bearing a methylpiperazine moiety. The drug has been cataloged in chemical databases but does not have an established clinical use or detailed mechanism of action reported in public sources. Its primary research interest appears to be as a chemical probe or lead compound for further medicinal chemistry development rather than as an approved pharmaceutical agent.[1][2][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine.